home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Food Drug & Cosmetic Act: Implementing Regulations & Major New Laws - An Overview - Webinar By GlobalCompliancePanel

 
  February 04, 2011  
     
 


GlobalCompliancePanel, Online Training Webinar
2011-03-01


Overview: Food, Drug, and Cosmetic Act history basics will be covered as will implementing FDA regulations relevant to the Food, Dietary Supplement and OTC Drug industries that have followed.

Some more recent major new regulations such as the Dietary Supplement Health & Education Act (DSHEA), the Bioterrorism Act,  and the Food Safety Modernization Act will also be covered.

Areas Covered In the Seminar:
  • History of the Food, Drug & Cosmetic (FD&C) Act
  • Amendments to the Food, Drug, & Cosmetic Law
  • Overview of Major Regulatory Actions Since the FD&C Act:
    • Fair Packaging & Labeling Act
    • OTC Drug Review - Development of OTC Monographs
    • Tamper Resistant Packaging Rule
    • Nutrition Labeling & Education Act (NLEA)
    • Dietary Supplement Health & Education Act (DSHEA)
    • OTC Drug Facts Labeling Rule
    • Bioterrorism Act
    • Food Safety Modernization Act
Who will benefit: Anyone who wants or needs basic background on the Food, Drug & Cosmetic Act and implementing regulations, as well as an overview of some major new rules relevant to the Food, Drug and Dietary Supplement industries. This includes:
  • Regulatory Professionals
  • Drug Marketers
  • Manufacturers and Distributors
  • Students of FDA Regulations
 
 
Organized by: GlobalCompliancePanel
Invited Speakers: Norma Skolnik has 30 years of regulatory experience in the OTC Drug, Food and Dietary Supplement industries. She has had extensive experience advising on regulatory strategies for new and marketed consumer healthcare products. Particularly regarding the development and review of optimal product claims and advertising. For 10 years, Norma served as Director of Regulatory Affairs for Cadbury Adams, Americas (formerly Adams Division of Pfizer). Previously she was Associate Director of Regulatory Affairs at Wyeth Consumer Healthcare and Associate Director, Regulatory Affairs at Lederle Consumer Health division of American Cyanamid.
 
Deadline for Abstracts: 2011-03-01
 
Registration: Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00
E-mail: webinars@GlobalCompliancePanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.